LifeMD announces a cash dividend of $0.5546875 per share for its 8.875% Series A Preferred Stock, payable October 15, 2026.
Quiver AI Summary
LifeMD, Inc. announced that its Board of Directors has approved a cash dividend of $0.5546875 per share for holders of its 8.875% Series A Cumulative Perpetual Preferred Stock, which will be paid on October 15, 2026, to shareholders on record as of October 2, 2026. LifeMD is a virtual care company that provides accessible and affordable healthcare through a comprehensive platform that includes a nationwide medical group, laboratory services, and an in-house pharmacy. The press release also includes cautionary notes regarding forward-looking statements, emphasizing that certain projections and expectations may change and that actual results can differ from those anticipated due to various uncertainties.
Potential Positives
- Authorization of a cash dividend of $0.5546875 per share for preferred stockholders demonstrates the company’s commitment to returning value to its investors.
- The dividend payment is scheduled for October 15, 2026, indicating the company’s financial stability and ability to meet its obligations.
- LifeMD's vertical integration of services highlights its comprehensive approach to virtual healthcare, enhancing its competitive advantage in the market.
Potential Negatives
- The announcement of a cash dividend may signal a lack of viable growth opportunities, leading to concerns about the company's long-term financial health and investment potential.
- The reliance on preferred stock dividends may indicate a vulnerability in cash flow or stability compared to common stockholders, potentially affecting investor confidence.
- The forward-looking statements section highlights numerous uncertainties and risks, which may contribute to investor apprehension regarding the company's future performance.
FAQ
What is LifeMD's recent dividend announcement?
LifeMD announced a cash dividend of $0.5546875 per share for its 8.875% Series A Preferred Stock.
When will the dividend be paid?
The dividend will be paid on October 15, 2026, to shareholders on record by October 2, 2026.
What services does LifeMD provide?
LifeMD offers virtual primary care, pharmacy services, and connects patients with various healthcare providers nationwide.
How can I learn more about LifeMD's services?
For more information, visit LifeMD's official website at LifeMD.com.
Where can I find LifeMD's financial filings?
You can access LifeMD's financial filings on the Securities and Exchange Commission's website or their investor relations page.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LFMD Revenue
$LFMD had revenues of $47.3M in Q2 2026. This is a decrease of -24.01% from the same period in the prior year.
You can track LFMD financials on Quiver Quantitative's LFMD stock page.
You can access data on LFMD stock through the Quiver Quantitative API.
$LFMD Hedge Fund Activity
We have seen 69 institutional investors add shares of $LFMD stock to their portfolio, and 54 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FEDERATED HERMES, INC. added 1,728,578 shares (+169.6%) to their portfolio in Q2 2026, for an estimated $7,139,027
- CITADEL ADVISORS LLC removed 826,936 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2,985,238
- ROYCE & ASSOCIATES LP removed 565,527 shares (-47.1%) from their portfolio in Q2 2026, for an estimated $2,335,626
- AQR CAPITAL MANAGEMENT LLC added 421,184 shares (+212.4%) to their portfolio in Q2 2026, for an estimated $1,739,489
- MILLENNIUM MANAGEMENT LLC added 401,624 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,658,707
- POINT72 ASSET MANAGEMENT, L.P. removed 399,094 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,440,729
- WHETSTONE CAPITAL ADVISORS, LLC removed 360,250 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $1,487,832
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$LFMD Price Targets
Multiple analysts have issued price targets for $LFMD recently. We have seen 2 analysts offer price targets for $LFMD in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Yi Chen from HC Wainwright & Co. set a target price of $10.0 on 05/26/2026
- David Larsen from BTIG set a target price of $10.0 on 05/04/2026
Full Release
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
The preferred dividend will be paid on October 15, 2026, to holders of record at the close of business on October 2, 2026.
About LifeMD, Inc.
LifeMD® is a leading virtual care company making high-quality healthcare more accessible, convenient, and affordable. Through its vertically integrated platform, LifeMD connects patients with a 50-state affiliated medical group, laboratory services, a state-of-the-art in-house pharmacy, and a U.S.-based patient care center. Together, these capabilities support care across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. For more information, please visit LifeMD.com .
Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.
Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.
Investor Contact
[email protected]
Media Contact
[email protected]